Elite Pharmaceuticals, Inc. Current Federal Tax Expense (Benefit)
Elite Pharmaceuticals, Inc. (ELTP) reported Current Federal Tax Expense (Benefit) of $784.58 thousand for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-29.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2023-06-29
- Elite Pharmaceuticals, Inc. current federal tax expense (benefit) for fiscal 2023 was $784.58K, a 32.41% decline from fiscal 2022.
- Elite Pharmaceuticals, Inc. current federal tax expense (benefit) for fiscal 2022 was $1.16M.
- Elite Pharmaceuticals, Inc. current federal tax expense (benefit) for fiscal 2018 was $0.00.
- Elite Pharmaceuticals, Inc. current federal tax expense (benefit) for fiscal 2017 was $0.00.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2023-03-31 | $784.58K 10-K · filed 2023-06-29 |
| 2022-03-31 | $1.16M 10-K · filed 2023-06-29 |
| 2018-03-31 | $0.00 10-K · filed 2018-06-14 |
| 2017-03-31 | $0.00 10-K · filed 2018-06-14 |
| 2016-03-31 | $0.00 10-K · filed 2018-06-14 |
| 2015-03-31 | $0.00 10-K · filed 2017-06-14 |
| 2014-03-31 | $0.00 10-K · filed 2016-06-15 |
| 2013-03-31 | $0.00 10-K · filed 2014-06-30 |
| 2012-03-31 | $0.00 10-K · filed 2013-06-21 |